| HMDB: a knowledgebase for the human metabolome DS Wishart, C Knox, AC Guo, R Eisner, N Young, B Gautam, DD Hau, ... Nucleic acids research 37 (suppl_1), D603-D610, 2009 | 2175 | 2009 |
| Targeted and untargeted proteomics approaches in biomarker development CA Sobsey, S Ibrahim, VR Richard, V Gaspar, G Mitsa, V Lacasse, ... Proteomics 20 (9), 1900029, 2020 | 128 | 2020 |
| Detailed Biophysical Characterization of the Acid-Induced PrPc to PrPβ Conversion Process TC Bjorndahl, GP Zhou, X Liu, R Perez-Pineiro, V Semenchenko, ... Biochemistry 50 (7), 1162-1173, 2011 | 118 | 2011 |
| Chicken Soup For The Teenage Soul II: 101 more stories of life, love and learning J Canfield, K Kirberger, MV Hansen Random House, 2011 | 52 | 2011 |
| Development and evaluation of a liquid chromatography–mass spectrometry method for rapid, accurate quantitation of malondialdehyde in human plasma CA Sobsey, J Han, K Lin, W Swardfager, A Levitt, CH Borchers Journal of Chromatography B 1029, 205-212, 2016 | 29 | 2016 |
| Systematic optimization of the iMALDI workflow for the robust and straightforward quantification of signaling proteins in cancer cells BC Froehlich, R Popp, CA Sobsey, S Ibrahim, AM LeBlanc, Y Mohammed, ... PROTEOMICS–Clinical Applications 14 (5), 2000034, 2020 | 12 | 2020 |
| Direct and precise measurement of bevacizumab levels in human plasma based on controlled methionine oxidation and multiple reaction monitoring VP Gaspar, S Ibrahim, CA Sobsey, VR Richard, A Spatz, RP Zahedi, ... ACS Pharmacology & Translational Science 3 (6), 1304-1309, 2020 | 7 | 2020 |
| A multiplexed, automated immuno-matrix assisted laser desorption/ionization mass spectrometry assay for simultaneous and precise quantitation of PTEN and p110α in cell lines … BC Froehlich, R Popp, CA Sobsey, S Ibrahim, A LeBlanc, Y Mohammed, ... Analyst 146 (21), 6566-6575, 2021 | 4 | 2021 |
| Immuno-MALDI-MS for Accurate Quantitation of Targeted Peptides from Volume-Restricted Samples CA Sobsey, B Froehlich, G Batist, CH Borchers Neuronal Cell Death: Methods and Protocols, 203-225, 2022 | 3 | 2022 |
| Protein quantitation assays for Akt, PI3K p110 alpha, and PTEN to assess PI3K pathway activity in tumor tissue CA Sobsey, R Popp, S Ibrahim, BC Froehlich, A Aguilar-Mahecha, ... MOLECULAR CANCER RESEARCH 18 (10), 51-52, 2020 | 1* | 2020 |
| Protein quantitation assays for AKT and PTEN to better understand sensitivity and resistance of breast cancer patients to treatment with AKT inhibitor capivasertib S Ibrahim, CA Sobsey, R Popp, RP Zahedi, G Batist, CH Borchers CANCER RESEARCH 80 (4), 2020 | 1* | 2020 |
| mTORC1-driven protein translation correlates with clinical benefit of capivasertib within a genetically preselected cohort of PIK3CA-altered tumours CA Sobsey, BC Froehlich, G Mitsa, S Ibrahim, R Popp, RP Zahedi, ... Cancer Research Communications, 2024 | | 2024 |
| Measurement of CYP1A2 and CYP3A4 activity by a simplified Geneva cocktail approach in a cohort of free-living individuals: a pilot study CA Sobsey, N Mady, VR Richard, A LeBlanc, T Zakharov, CH Borchers, ... Frontiers in Pharmacology 15, 1232595, 2024 | | 2024 |
| Quantifying protein expression and activity complements genetics to optimize the use of targeted therapies in precision oncology CA Sobsey McGill University (Canada), 2023 | | 2023 |
| The metabolomics of chronic stress CA Sobsey | | 2016 |
| The Prionet Prion Protein and Plasmid Production Platform Facility (PrP5) BP Suriyamongkol, A Abera, V Semenchenko, C Sobsey, DS Wishart PRION 5, 87-88, 2011 | | 2011 |
| Is the Prion Protein an Innate Immune Response Protein? BN Ametaj, SM Dunn, TC Bjorndhal, F Saleem, R Perez-Pineiro, ... PRION 5, 23-24, 2011 | | 2011 |
| Conversion of Syrian Hamster Prion Protein to Beta Oligomer and Fibril Forms Under Physiological PH Conditions VV Semenchenko, TC Bjorndahl, X Liu, GP Zhou, F Saleem, S Acharya, ... PRION 4 (3), 123-123, 2010 | | 2010 |
| Lipopolysaccharide Interacted with Prion Protein and Converted it into a beta-sheet-rich Isoform Resistant to Proteinase K BN Ametaj, F Saleem, V Semenchenko, C Sobsey, DS Wishart PRION 4 (3), 123-124, 2010 | | 2010 |
| PPo1-15: Conversion of Syrian Hamster Prion Protein to Beta Oligomer and Fibril Forms Under Physiological PH Conditions V Semenchenko, T Bjorndahl, X Liu, GP Zhou, F Saleem, S Acharya, ... Prion 4 (3), 0 | | |
David WishartProfessor, Depts. of Computing Science and Biological Sciences - University of AlbertaVerified email at ualberta.ca
